Abstract
The role of tumor-induced immune modulation in cancer progression is currently a focus of investigation. The signal transducer and activator of transcription 3 (STAT3) is an established molecular hub of immunosuppression, and its signaling pathways are classically overactivated within malignancies. This article will review STAT3 operational mechanisms within the immune system and the tumor microenvironment, with a focus on therapeutic strategies that may impact outcomes for patients with cancer.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 385-394 |
| Number of pages | 10 |
| Journal | Journal of neuro-oncology |
| Volume | 123 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jul 23 2015 |
Keywords
- Glioblastoma
- Immune suppression
- STAT3
ASJC Scopus subject areas
- Oncology
- Neurology
- Clinical Neurology
- Cancer Research
Fingerprint
Dive into the research topics of 'The role of STAT3 in tumor-mediated immune suppression'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS